Dr Faith Howard
PhD, BSc (Hons).
Clinical Medicine, School of Medicine and Population Health
Postdoctoral Research Associate
Full contact details
Clinical Medicine, School of Medicine and Population Health
EU27, E Floor
The Medical School
Beech Hill Road
91直播
S10 2RX
- Profile
-
I joined the University of 91直播 in 2006 as a research technician where I completed a PhD in the Academic Unit of Nephrology in 2013 involving CDK/MEK inhibitors to inhibit fibrosis. In 2011 I joined the department of Clinical Oncology working on breast cancer and metastasis. I have multi-disciplinary, cross-sector experience having worked in industry between the years 2014-2018 in the AMR field before returning to the University of 91直播 and the study of breast cancer. My current research involves .
- Research interests
-
My research interests are focused on delivery of therapeutics to disseminated tumours. This includes nanoenabled formulations and the development of appropriate models for studying immunotherapies.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Frontiers in Molecular Biosciences, 9.
- . Small.
- . Nanomedicine, 15(1), 93-110.
- . Breast Cancer Research, 21(1).
- . Current Pharmaceutical Design, 25(17), 1962-1979.
- . Clinical Cancer Research, 25(9), 2769-2782.
- . Clinical & Experimental Metastasis, 33(3), 211-224.
- . Clinical & Experimental Metastasis, 32(7), 689-702.
- . Endocrine-Related Cancer, 21(2), 327-341.
- . Cellular Oncology, 36(6), 505-514.
- . Nephron Experimental Nephrology, 122(3-4), 114-122.
- . Breast Cancer Research, 14(3).
- . PLOS ONE, 10(9), e0137321-e0137321.
Chapters
All publications
Journal articles
- . Journal of Clinical Oncology, 41(23), 3881-3890.
- . Nanotheranostics, 7(1), 102-116.
- . Future Pharmacology, 2(4), 444-459.
- . Viruses, 14(7).
- . Frontiers in Molecular Biosciences, 9.
- . Small.
- . Nanomedicine: Nanotechnology, Biology and Medicine, 40.
- . Nanomedicine, 15(1), 93-110.
- . Breast Cancer Research, 21(1).
- . Current Pharmaceutical Design, 25(17), 1962-1979.
- . Clinical Cancer Research, 25(9), 2769-2782.
- . Breast Cancer Research, 19.
- . Scientific Reports, 6(1).
- . Clinical & Experimental Metastasis, 33(3), 211-224.
- . Clinical & Experimental Metastasis, 32(7), 689-702.
- . Endocrine-Related Cancer, 21(2), 327-341.
- . Cellular Oncology, 36(6), 505-514.
- . Nephron Experimental Nephrology, 122(3-4), 114-122.
- . Breast Cancer Research, 14(3).
- . Radiology, 263(1), 107-116.
- . Poster Session Abstracts.
- . Investigative Radiology, 45(9), 507-512.
- . OMEGA - Journal of Death and Dying, 003022282211155-003022282211155.
- . PLOS ONE, 10(9), e0137321-e0137321.
- . Bone Abstracts.
Chapters
- , Systemic Drug Delivery Strategies (pp. 211-230). Elsevier
- , Biomedical Engineering IntechOpen
- , Liposomes - Recent Advances, New Perspectives and Applications IntechOpen
Conference proceedings papers
- Research group
-
Member of Nanobug Oncology 91直播 () team led by Dr Munitta Muthana.
- Grants
-
2022 British Association of Cancer, Roger Griffin Prize for Cancer Discovery.
2022 Early Career Researcher Prize for Outstanding Contribution to Research, Engagement and Leadership by Faculty of Medicine, Dentistry & Health, University of 91直播.
2019 EPSRC NanoPrime Grant (EP/K005138/1A).
2018 CRUK New Investigator Committee - Research Travel Award.
- Teaching interests
-
I teach Immunology on the MBChB course and am module lead for Home Office Personal Licence holders. I also supervise research projects for the medical school MSc. Molecular Medicine and MSc. Translational Oncology courses.
- Professional activities and memberships
-
- Steering Committee member of the ECMC Junior Investigator Networking Group.
- Member of NCRI ECR Forum.
- Member of UKRI ECR Forum.
- Reviewer for ACS Nano, ACS Applied Materials and Interfaces, Advanced Therapeutics.